Literature DB >> 26722589

Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia.

Takashi Higo1, Takashi Kobayashi1, Sho Yamazaki1, Sumiyo Ando2, Wataru Gonoi3, Masanori Ishida3, Hidemi Okuma4, Fumihiko Nakamura1, Tetsuo Ushiku2, Kuni Ohtomo3, Masashi Fukayama2, Mineo Kurokawa1.   

Abstract

Invasive mucormycosis in patients with hematological diseases mostly occurs in the lungs. Invasive mucormycosis of other anatomical sites is relatively infrequent and its pathogenesis has not so far been well elucidated. Here, we describe an autopsy case of pulmonary invasive mucormycosis complicated by cerebral embolism with infarct. A 77-year-old Japanese woman with relapsed acute myeloid leukemia complained of left visual disturbance and weakness of the lower limbs. The diagnosis of leukemic infiltration to the central nervous system was made. Repeated intrathecal injection of methotrexate plus cytarabine resulted in partial amelioration of the neurologic symptoms. However, the patient then developed fever, dyspnea, and subsequent right hemiparesis. A computed tomography (CT) scan showed a consolidative shadow with halo sign in the left lung field, which was compatible with either invasive pulmonary aspergillosis or mucormycosis. These findings accounted for fever and dyspnea, but not hemiparesis. Despite antifungal therapy, the patient succumbed to death after two weeks. Autopsy revealed pulmonary invasive mucormycosis with a fungal ball in the lumina of the adjacent ascending aorta. Intriguingly, autopsy and postmortem CT scan identified left cerebral infarct due to mucormycosis, which accounted for the right hemiparesis. It is likely that the fungal ball caused the cerebral embolism through hematogenous dissemination. We should suspect hematogenous dissemination when we see a patient with pulmonary invasive mucormycosis developing neurologic symptoms.

Entities:  

Keywords:  Cerebral embolism; hematogenous dissemination; invasive mucormycosis; relapsed acute myeloid leukemia

Mesh:

Substances:

Year:  2015        PMID: 26722589      PMCID: PMC4680534     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

Review 1.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

2.  The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Massimo Offidani; Luana Fianchi; Bruno Martino; Domenico Pastore; Marco Picardi; Alessandro Bonini; Anna Chierichini; Rosa Fanci; Cecilia Caramatti; Rosangela Invernizzi; Daniele Mattei; Maria Enza Mitra; Lorella Melillo; Franco Aversa; Maria Teresa Van Lint; Paolo Falcucci; Caterina Giovanna Valentini; Corrado Girmenia; Annamaria Nosari
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

Review 3.  How I treat mucormycosis.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

4.  Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis.

Authors:  J Eucker; O Sezer; R Lehmann; J R Weber; B Graf; C Denkert; W Brück; M Schweigert; K Possinger
Journal:  Infection       Date:  2000 Jul-Aug       Impact factor: 3.553

Review 5.  Mucormycosis in hematologic patients.

Authors:  Livio Pagano; Massimo Offidani; Luana Fianchi; Annamaria Nosari; Anna Candoni; Marco Picardi; Laura Corvatta; Domenico D'Antonio; Corrado Girmenia; Pietro Martino; Albano Del Favero
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

Review 6.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

7.  Rhinocerebral mucormycosis: changing patterns of disease.

Authors:  E S Nussbaum; W A Hall
Journal:  Surg Neurol       Date:  1994-02
  7 in total
  4 in total

1.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

Review 2.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

3.  Case Report: Metagenomics Next-Generation Sequencing for Diagnosing Cerebral Infarction and Infection Caused by Hematogenous Disseminated Mucormycosis in a Patient With Acute Lymphoblastic Leukemia.

Authors:  Bingbing Wen; Lisheng Cai; Yun Cai; Xin Du
Journal:  Front Med (Lausanne)       Date:  2021-12-17

4.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.